Lynn Institute conducts clinical trials for patients diagnosed with Diabetic Peripheral Neuropathy (DPN). These trials aim to evaluate the effectiveness of new medications and therapies in managing pain, improving nerve function, and enhancing the quality of life for individuals living with this condition. Participants receive comprehensive medical care and compensation for their time and travel.